NANJING, China, Oct. 21 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical
Group (NYSE: SCR), a leading manufacturer and supplier of branded generic
pharmaceuticals and innovative anti-cancer pharmaceuticals in the rapidly
growing China market, announced today that it intends to release its 2008
third quarter results on Thursday, November 6, 2008, before the market
opens in the United States. Simcere's chief executive officer, Jinsheng
Ren, and chief financial officer, Frank Zhigang Zhao, will host an earnings
conference call to discuss the company's 2008 third quarter results on
Thursday, November 6, at 8 a.m. ET (Thursday, November 6, at 9 p.m.
Beijing/Hong Kong time).
To access the conference call, please dial:
United States toll-free dial-in number: +1-866-314-4483
United States toll / International dial-in number: +1-617-213-8049
China toll-free dial-in number: 10-800-130-0399
Hong Kong dial-in number: +852-3002-1672
Please ask to be connected to Simcere's Q3 2008 Earnings Call and provide the following passcode: 91351092. Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's Web site at http://www.simcere.com .
Following the earnings conference call, an archive of the call will be
available by dialing:
United States toll-free dial-in number: +1-888-286-8010
United States toll / International dial-in number: +1-617-801-6888
The passcode for replay participants is: 53343092. The telephone replay
also will be archived on the "I
|SOURCE Simcere Pharmaceutical Group|
Copyright©2008 PR Newswire.
All rights reserved